Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...

CLEVELAND — Childhood cancer is the No. 1 disease-related cause of death among children in the United States, with one in six young patients not surviving. For families grappling with a cancer ...

Fusion oncoproteins, such as those that cause the rare cancer Ewing sarcoma, are promising targets for new cancer drugs. However, the nature of these abnormal molecules poses challenges in drug ...

Ewing sarcoma is a tumor of the bones and soft tissues that occurs in children and young people. Like all childhood cancers, it is rare – 9 to 10 cases per million inhabitants per year – but it is ...

Actuate Therapeutics, Inc. has announced the completion of the Phase 1 study evaluating its drug elraglusib in pediatric patients with refractory malignancies, specifically Ewing Sarcoma (EWS). The ...